C07C51/347

ACTIVE ZINC-BASED CATALYST AND PREPARATION METHOD THEREOF, AND USE IN CATALYZING REARRANGEMENT REACTION OF IBUPROFEN

The present disclosure provides an active zinc-based catalyst and a preparation method thereof, and use in catalyzing a rearrangement reaction of ibuprofen. The active zinc-based catalyst includes a carbon-based fiber material and nano-zinc oxide supported on a fiber surface of the carbon-based fiber material. The active zinc-based catalyst is introduced with the carbon-based fiber material, and the carbon-based fiber material is capable of increasing a specific surface area of the catalyst, thereby improving a dispersion degree of zinc oxide, increasing the number of catalytic active sites, and significantly improving a catalytic activity. Meanwhile, due to a certain mechanical strength, the carbon-based fiber material is capable of improving a mechanical strength of the catalyst, making the catalyst exist stably in ketal fluid, maintaining a stable morphology of the catalyst, and avoiding or inhibiting reduction of the catalytic active sites, thereby ensuring a catalytic stability.

FORMATE PRODUCTION METHOD, FORMIC ACID PRODUCTION METHOD, CATALYST FOR PRODUCING FORMATE, AND RUTHENIUM COMPLEX

The invention relates to a method for producing a formate, the method including reacting hydrogen with carbon dioxide, a hydrogen carbonate or a carbonate using a catalyst in the presence of a solvent, wherein the reaction is a two-phase system in which an organic solvent and an aqueous solvent are present in a separated state in the solvent, and the catalyst is at least one selected from a ruthenium complex represented by the formula (1) in the specification, a tautomer or stereoisomer thereof, and a salt compound of the complex, tautomer or stereoisomer.

Active zinc-based catalyst and preparation method thereof, and use in catalyzing rearrangement reaction of ibuprofen

The present disclosure provides an active zinc-based catalyst and a preparation method thereof, and use in catalyzing a rearrangement reaction of ibuprofen. The active zinc-based catalyst includes a carbon-based fiber material and nano-zinc oxide supported on a fiber surface of the carbon-based fiber material. The active zinc-based catalyst is introduced with the carbon-based fiber material, and the carbon-based fiber material is capable of increasing a specific surface area of the catalyst, thereby improving a dispersion degree of zinc oxide, increasing the number of catalytic active sites, and significantly improving a catalytic activity. Meanwhile, due to a certain mechanical strength, the carbon-based fiber material is capable of improving a mechanical strength of the catalyst, making the catalyst exist stably in ketal fluid, maintaining a stable morphology of the catalyst, and avoiding or inhibiting reduction of the catalytic active sites, thereby ensuring a catalytic stability.

Active zinc-based catalyst and preparation method thereof, and use in catalyzing rearrangement reaction of ibuprofen

The present disclosure provides an active zinc-based catalyst and a preparation method thereof, and use in catalyzing a rearrangement reaction of ibuprofen. The active zinc-based catalyst includes a carbon-based fiber material and nano-zinc oxide supported on a fiber surface of the carbon-based fiber material. The active zinc-based catalyst is introduced with the carbon-based fiber material, and the carbon-based fiber material is capable of increasing a specific surface area of the catalyst, thereby improving a dispersion degree of zinc oxide, increasing the number of catalytic active sites, and significantly improving a catalytic activity. Meanwhile, due to a certain mechanical strength, the carbon-based fiber material is capable of improving a mechanical strength of the catalyst, making the catalyst exist stably in ketal fluid, maintaining a stable morphology of the catalyst, and avoiding or inhibiting reduction of the catalytic active sites, thereby ensuring a catalytic stability.

Method For Vaporizing Lactic Acid, Apparatus For Vaporizing Lactic Acid, And Method For Preparing Acrylic Acid From Lactic Acid
20230382842 · 2023-11-30 · ·

The present disclosure relates to a method and an apparatus for vaporizing lactic acid. According to the method and apparatus, the content of lactic acid oligomers can be reduced within a short period of time, and the content of single-molecule lactic acid can be increased. The method includes heating and pressurizing a lactic acid aqueous solution, spraying a 1-1 stream of a liquid phase containing the heated and pressurized lactic acid aqueous solution, vaporizing the lactic acid contained in the 1-1 stream through spraying; and obtaining a 1-3 stream of a gas phase containing single-molecule lactic acid.

Method For Vaporizing Lactic Acid, Apparatus For Vaporizing Lactic Acid, And Method For Preparing Acrylic Acid From Lactic Acid
20230382842 · 2023-11-30 · ·

The present disclosure relates to a method and an apparatus for vaporizing lactic acid. According to the method and apparatus, the content of lactic acid oligomers can be reduced within a short period of time, and the content of single-molecule lactic acid can be increased. The method includes heating and pressurizing a lactic acid aqueous solution, spraying a 1-1 stream of a liquid phase containing the heated and pressurized lactic acid aqueous solution, vaporizing the lactic acid contained in the 1-1 stream through spraying; and obtaining a 1-3 stream of a gas phase containing single-molecule lactic acid.

Site-specific isotopic labeling of 1,4-diene systems

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.

Site-specific isotopic labeling of 1,4-diene systems

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.

Site-specific isotopic labeling of 1,4-diene systems

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.

Site-specific isotopic labeling of 1,4-diene systems

Methods for preparing isotopically modified 1,4-diene systems from non-isotopically modified 1,4-dienes involve selective oxidation of one or more bis-allylic position(s), or the preparation of isotopically modified 1,4-diene systems via trapping pi-allylic complexes with a source of deuterium or tritium. Such methods are useful for preparing isotopically modified polyunsaturated lipid including polyunsaturated fatty acids and polyunsaturated fatty acid derivatives.